The effects of haloperidol treatment on the distribution of NK1 receptor immunoreactive neurons in guinea-pig brain

被引:4
作者
Tooney, PA [1 ]
Anderson, WB
Lynch-Frame, A
Chahl, LA
机构
[1] NISAD, Sydney, NSW, Australia
[2] Univ Newcastle, Fac Hlth, Sch Biomed Sci, Callaghan, NSW 2308, Australia
关键词
tachykinins; NK1; receptor; haloperidol; schizophrenia; guinea pig;
D O I
10.1016/j.neulet.2005.04.012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previous studies have observed increased tachykinin NK1 receptor immunoreactivity (NK1-IR) in the prefrontal cortex in subjects with schizophrenia. Since the subjects were medicated the possibility of a treatment effect could not be excluded. Thus, the present study was undertaken to determine the effect of chronic treatment with the antipsychotic drug, haloperidol, on the distribution of NK1-IR neurons in the guinea-pig brain. Guinea pigs were treated each day for 21 days with either haloperidol (1 mg/kg) or vehicle and the brains were then processed for immumohistochemistry using an NK1 receptor-specific polyclonal antibody. NK1-IR neurons and fibres were abundant in the forebrain cortex and caudate putamen and more sparsely distributed in a number of other brain regions. The relative density of NK1-IR neurons was significantly increased in the forebrain cortex, but not in the caudate putamen in guinea pigs treated with haloperidol. This study has shown that haloperidol causes region-specific changes to the density of NK1-IR neurons. Whether these changes are related to the therapeutic effects or to the side effects of haloperidol in individuals with schizophrenia, remains to be determined. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:155 / 159
页数:5
相关论文
共 21 条
[1]   EFFECT OF TYPICAL AND ATYPICAL NEUROLEPTIC TREATMENT ON PROTACHYKININ MESSENGER-RNA LEVELS IN THE STRIATUM OF THE RAT [J].
ANGULO, JA ;
CADET, JL ;
MCEWEN, BS .
NEUROSCIENCE LETTERS, 1990, 113 (02) :217-221
[2]   NK1 RECEPTOR EXPRESSION BY CHOLINERGIC INTERNEURONS IN HUMAN STRIATUM [J].
AUBRY, JM ;
LUNDSTROM, K ;
KAWASHIMA, E ;
AYALA, G ;
SCHULZ, P ;
BARTANUSZ, V ;
KISS, JZ .
NEUROREPORT, 1994, 5 (13) :1597-1600
[3]   BEHAVIORAL-EFFECTS OF SELECTIVE DOPAMINE-D-1 AND DOPAMINE-D-2 AGONISTS AND ANTAGONISTS IN GUINEA-PIGS [J].
BRENT, PJ .
PSYCHOPHARMACOLOGY, 1991, 104 (02) :201-207
[4]   Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain [J].
Caberlotto, L ;
Hurd, YL ;
Murdock, P ;
Wahlin, JP ;
Melotto, S ;
Corsi, M ;
Carletti, R .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 17 (09) :1736-1746
[5]  
HUMPEL C, 1990, SYNAPSE, V6, P1
[6]   Autoradiographic localisation of substance P (NK1) receptors in human primary visual cortex [J].
Kus, L ;
Mazzone, SB ;
Paxinos, G ;
Geraghty, DP .
BRAIN RESEARCH, 1998, 794 (02) :309-312
[7]   Peripheral actions of tachykinins [J].
Lecci, A ;
Giuliani, S ;
Tramontana, M ;
Carini, F ;
Maggi, CA .
NEUROPEPTIDES, 2000, 34 (05) :303-313
[8]   NEUROLEPTIC TREATMENT INDUCES REGION-SPECIFIC CHANGES IN LEVELS OF NEUROKININ-A AND SUBSTANCE-P IN RAT-BRAIN [J].
LINDEFORS, N ;
BRODIN, E ;
UNGERSTEDT, U .
NEUROPEPTIDES, 1986, 7 (03) :265-280
[9]   Effect of chronic antipsychotic drug treatment on preprosomatostatin and preprotachykinin A mRNA levels in the medial prefrontal cortex, the nucleus accumbens and the caudate putamen of the rat [J].
Marcus, MM ;
Nomikos, GG ;
Malmerfelt, A ;
Zachrisson, O ;
Lindefors, N ;
Svensson, TH .
MOLECULAR BRAIN RESEARCH, 1997, 45 (02) :275-282
[10]   DIFFERENTIAL INCREASES OF NEUROKININ B-LIKE AND ENKEPHALIN-LIKE IMMUNOREACTIVITIES AND THEIR MESSENGER-RNAS AFTER CHRONIC HALOPERIDOL TREATMENT IN THE RAT [J].
MARKSTEINER, J ;
SARIA, A ;
MILLER, CH ;
KRAUSE, JE .
NEUROSCIENCE LETTERS, 1992, 148 (1-2) :55-59